WASHINGTON – Vision scientists at Washington University School of Medicine in St. Louis have found an intricate process that allows the human eye to adapt to darkness very quickly. The discovery could contribute to better understanding of human diseases that affect the retina, including age-related macular degeneration. Age-related macular degeneration may be modulated, perhaps, through this pathway [...]
Investigators from Boston University School of Medicine (BUSM) and the VA Boston Healthcare System have shown, at 6 months in a small group of patients, that there is no difference in efficacy between Bevacizumab (Avastin) and Ranibizumab (Lucentis) for the treatment of age-related macular degeneration (AMD).
Health, wellness, and nutrition news to advance integrative medicine.
Researchers at the University of North Carolina at Chapel Hill School of Medicine in collaboration with lead investigators at the University of Kentucky have identified a new target for the diagnosis and treatment of age-related macular degeneration, the most common cause of blindness in older Americans.
London, June 15 (ANI): Scientists have identified a new target for the diagnosis and treatment of age-related macular degeneration. In a study, researchers at the University of North Carolina at Chapel Hill School of Medicine in collaboration with lead investigators at the University of Kentucky have demonstrated that blocking the activity of a specific protein – [...]
